SEC Form 4 · accession 0001209191-15-000210
Alaunos Therapeutics, Inc. · TCRT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin G Lafond
Officer — Vice Pres., Treasurer, & CAO
Period of report
Dec 30, 2014
Accepted (ET)
Jan 2, 2015 · 4:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001107421
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 30, 2014 | F | 4,690 | $5.03 | D | 26,666 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $5.07 | Dec 31, 2014 | A | 75,000 | A | — | Dec 30, 2024 | Common Stock | 75,000 | 75,000 | D |
Explanation of responses
- F1Represents shares withheld to satisfy withholding obligation upon the vesting of restricted stock grants.
- F225,000 shares shall vest on 12/31/2015, 12/31/2016 and 12/31/2017.